Mabvax Therapeutics Holdings Inc (NASDAQOTH:MBVX)

CAPS Rating: 1 out of 5

A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

58 Outperform
56 Underperform
 

All-Star Players

5 Outperform
24 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top MBVX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

PueoFool (< 20)
Submitted February 27, 2008

This is my vegas-style gamble for the week.

YeahBuddy79 (96.75)
Submitted May 06, 2008

Embarrassing at best. All the posts have already noted the deaths and that it kills people. As if that is not enough for you, this stock has a bad track record and it is falling faster then Cheney's approval rating. Not trying to get political (but… More

MBVX VS S&P 500 (SPY)

Fools bullish on MBVX are also bullish on:

Fools bearish on MBVX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MBVX.

Recs

5
Member Avatar YeahBuddy79 (96.75) Submitted: 5/5/2008 10:56:39 PM : Underperform Start Price: $194.40 MBVX Score: +192.68

Embarrassing at best. All the posts have already noted the deaths and that it kills people. As if that is not enough for you, this stock has a bad track record and it is falling faster then Cheney's approval rating. Not trying to get political (but it is true). Alright if you don’t know by now I really feel sorry for you. NEVER invest in the “cure for cancer” they will not find a cure they will find away to make you live with it. Don’t like that tuff break. The truth hurts. It is not like I want that don’t kill the informer. To be honest with you no company should be able to survive this. If it does I buy the CEOs a trophy for best killer that got away with it.

Recs

2
Member Avatar PueoFool (< 20) Submitted: 2/27/2008 12:33:39 PM : Outperform Start Price: $243.00 MBVX Score: -195.54

This is my vegas-style gamble for the week.

Recs

0
Member Avatar invstm1000 (< 20) Submitted: 10/22/2007 7:48:52 PM : Underperform Start Price: $345.60 MBVX Score: +180.11

lousy management, questionable drug, all in all these is easy money selling short.

Leaderboard

Find the members with the highest scoring picks in MBVX.

Score Leader

zzlangerhans

zzlangerhans (99.85) Score: +321.19

Never write a biopharma off completely, especially when it comes to CAPS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
applefoot 65.57 9/13/2006 Underperform 3M $1,525.50 -99.98% +111.00% +210.98 0 Comment
studpicker 30.34 2/15/2008 Underperform NS $234.00 -99.90% +102.63% +202.52 0 Comment
ToePic < 20 2/25/2008 Underperform NS $235.80 -99.90% +100.28% +200.18 0 Comment
foolishDAG 99.72 3/14/2007 Underperform NS $482.40 -99.95% +99.72% +199.67 0 Comment
schwah4 29.07 4/3/2008 Underperform NS $235.80 -99.90% +97.19% +197.09 0 Comment
invstm100 < 20 6/9/2008 Underperform NS $173.70 -99.86% +97.08% +196.94 0 Comment
RagTimeCharley 87.90 3/21/2007 Underperform 5Y $495.90 -99.95% +95.07% +195.02 0 Comment
kesterdave < 20 12/20/2006 Underperform 3M $1,488.60 -99.98% +94.43% +194.41 0 Comment
AugustGray < 20 12/20/2006 Underperform NS $1,459.80 -99.98% +94.37% +194.35 0 Comment
Comatosis2007 < 20 12/28/2006 Underperform 1Y $396.00 -99.94% +94.14% +194.08 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackIcahn 89.94 9/30/2007 Outperform NS $261.90 -86.26% -51.07% -35.18 2/24/2009 @ $35.99 1 Comment
TrackJanney 85.07 12/27/2006 Underperform NS $423.00 +45.11% +3.62% -41.48 4/17/2007 @ $613.80 0 Comment
TrackStifel 91.89 12/27/2006 Underperform NS $423.00 +49.79% +3.77% -46.02 4/17/2007 @ $633.60 0 Comment
TrackLehmanBros < 20 11/15/2006 Underperform NS $1,620.00 -85.39% -3.14% +82.25 2/14/2008 @ $236.70 0 Comment

Advertisement